ACTRN12612001241820尚未招募未知
A pilot study on the effects of intermittent and graded exercise compared to no exercise for optimising health and reducing symptoms in Chronic Fatigue Syndrome (CFS)patients.
Suzanne Broadbent0 个研究点目标入组 60 人开始时间: 2012年11月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Medical diagnosis of Chronic Fatigue Syndrome: persistent and disabling, and/or recurring, fatigue lasting for more than 6 months, that does not result from physical exertion and that is not alleviated by rest. Other symptoms include muscle weakness and pain, ongoing medical symptoms such as swollen lymph nodes and fever, poor sleep, poor concentration and reduced quality of life.
排除标准
- •Diagnosed cardiac and/or respiratory disease; joint or muscle condition/disease other than CFS, that is contraindicated for exercise; any mental health condition that may affect exercise participation or safety of participant and researchers.
研究者
相似试验
已完成
4 期
Comaparison of cisatracurium muscle relaxant administered via two different moethods during surgical procedures under general anaesthesiaCTRI/2021/01/030232Department of Anaesthesiology60
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of thesurface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1Level: LLTClassification code 10049280Term: Solid tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-ITASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.199
进行中（未招募）
1 期
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1 Level: LLT Classification code 10049280 Term: Solid tumour System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10066697 Term: Ovarian cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-GBAstellas Pharma Global Development, Inc.210
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsEUCTR2009-010319-34-PLAstellas Pharma Global Development, Inc.199
进行中（未招募）
不适用
A clinical trial investigating OSI-906 in patients with cancer of the surface of the ovary and other solid tumorsRecurrent Epithelial Ovarian Cancer and Other Solid TumorsMedDRA version: 14.1Level: LLTClassification code 10049280Term: Solid tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10066697Term: Ovarian cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-010319-34-CZAstellas Pharma Global Development, Inc.199